Regeneron will use trove of 23andMe genetic data to develop medical advances.
Source: Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica
Regeneron will use trove of 23andMe genetic data to develop medical advances.
Source: Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica